AMDL, Inc.
Gene therapy may be useful in cancer treatments
Published in Biotech Law Weekly, July 2nd, 2004
AMDL, Inc., (ADL), which recently announced that it has launched an effort to seek a strategic partner for clinical trials and marketing of its Combination Immunogene Therapy (CIT), said the important U.S. patent it recently received highlights new gene therapy compositions that might be useful in treating specific forms of cancer and details the development of mice that will be far more useful in animal studies because of their human-like immune system.
Specifically, a "humanized" mouse is claimed by AMDL that has been engineered to possess a human-like immune system. This transgenic mouse is extremely useful for studying potential therapeutic benefits of candidate...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2004-07-02)
More Articles from Biotech Law Weekly
- Advanced Biotherapy, Inc.
U.S. patent granted for asthma, allergy treatment - Biotechnology
BioShield shortcomings subject of industry conference - Centers for Medicare & Medicaid Services
CMS and NCI collaborate to bring new drugs, better treatment to cancer patients - Centers for Medicare & Medicaid Services
Initiative helps low-income beneficiaries sign up for drug discount card - Centers for Medicare and Medicaid Services
ACCC calls on CMS to allow for exceptions to ASP reimbursement - Drug Discount Card
Blue Cross Blue Shield of Missouri offers drug card - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
